Valerio Therapeutics Société anonyme (EPA:ALVIO)

EPA:ALVIO Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Revenue	2.57	1.79	1.8	1.44	4.06
Revenue	2.57	1.79	1.8	1.44	4.06
Revenue Growth (YoY)	43.50%	-0.39%	24.74%	-64.48%	128.72%
Cost of Revenue	0.85	0.51	0.53	0.51	0.37
Gross Profit	1.73	1.28	1.27	0.93	3.69
Selling, General & Admin	4.68	13.95	19.57	18.02	8.12
Other Operating Expenses	-3.59	0.56	0.27	0.03	0.69
Operating Expenses	2.28	17.77	20.32	18.04	9.28
Operating Income	-0.55	-16.49	-19.05	-17.11	-5.58
Interest Expense	-0.28	-	-0.14	-2.19	-0.85
Interest & Investment Income	0.09	0.48	0.17	0.14	0.01
Earnings From Equity Investments	-3.8	-8.02	-	-	-
Other Non Operating Income (Expenses)	-0.1	-0.31	-0.07	-0.5	0.15
EBT Excluding Unusual Items	-4.64	-24.34	-19.09	-19.67	-6.28
Other Unusual Items	-	0.79	-1.23	0.39	0.44
Pretax Income	-4.64	-23.55	-20.33	-19.28	-5.84
Income Tax Expense	0.26	0.38	0.02	0.29	0.1
Net Income	-4.9	-23.93	-20.34	-19.56	-5.94
Net Income to Common	-4.9	-23.93	-20.34	-19.56	-5.94
Shares Outstanding (Basic)	274	154	135	106	88
Shares Outstanding (Diluted)	274	154	135	106	88
Shares Change (YoY)	78.10%	13.81%	27.86%	19.88%	17.03%
EPS (Basic)	-0.02	-0.16	-0.15	-0.18	-0.07
EPS (Diluted)	-0.02	-0.16	-0.15	-0.18	-0.07
Free Cash Flow	0.52	-12.78	-17.57	-9.93	-8.71
Free Cash Flow Per Share	0.00	-0.08	-0.13	-0.09	-0.10
Gross Margin	67.08%	71.39%	70.39%	64.38%	90.94%
Operating Margin	-21.38%	-919.69%	-1058.50%	-1185.93%	-137.42%
Profit Margin	-190.36%	-1334.69%	-1130.22%	-1355.65%	-146.16%
Free Cash Flow Margin	20.25%	-712.72%	-976.33%	-688.22%	-214.45%
EBITDA	3.45	-3.9	-18.92	-17.04	-5.54
EBITDA Margin	134.09%	-217.29%	-	-	-136.26%
D&A For EBITDA	4	12.59	0.14	0.08	0.05
EBIT	-0.55	-16.49	-19.05	-17.11	-5.58
EBIT Margin	-21.38%	-	-	-	-137.42%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.